Skip to main content
Log in

Q-fever and autoimmunity

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Study objective: To determine the incidence and the clinical significance of two autoimmune markers in Q-fever (smooth muscle antibodies, cold agglutinins).

Design: Six index cases with auto-immune disorders.

Assays of 104 sera from patients with Q-fever (including index cases) using immunofluorescence for smooth muscle antibodies, microagglutination for cold agglutinins.

Setting: French National Reference Center for Rickettsial Diseases.

Cases: 6 patients were studied with acute Q-fever and auto-immune disorders. 3 of whom had presented a resistance to a therapy with antibiotics. Stored samples from other patients with acute or chronic stage were also screened to appreciate the incidence of the two markers.

Measurements and main results: Case reports: No correlation between Q-fever and smooth muscle antibodies titers and kinetics were found.

A spurt of corticosteroids was necessary to obtain apyrexia for the patients who had presented multiple auto-immune disorders and a resistance to the classical therapy.

Incidence: Smooth muscle antibodies were detected in 27%, cold agglutinins in one case. They were present in 23% of the patients with acute cases and in 38% with chronic stage.

Conclusion: The incidence of auto-immune disorders is unexpectedly high and could explain some manifestations of acute Q-fever e.g the resistance to therapy with antibiotics which are not yet clear. Then the association during the acute stage of auto-immune disorders with the persistance of clinical or biological findings after three weeks therapy could recommend the use of corticosteroids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Arlet Ph. H., Botreau Y., Duffaut N. and Le Tallec Y. (1981): Anticoagulant circulant au cours d'une syphilis primosecondaire et de la fievre Q. Nouv. Presse Med. 10: 2909.

    Google Scholar 

  2. Auvergnat J. C., Couret B., Fauveau U., Lareng M.B., Puel J. and Armengaud M. (1976): L'hepatite granulomateuse de la fievre Q: un diagnostic a evoquer devant une fievre prolongee d'etiologie obscure. — J. Agreges 9: 190–195.

    Google Scholar 

  3. Bachaud N., Massip P., Boneu B. and Armengaud M. (1983): Inhibiteur acquis du facteur antihemophilique B (facteur IX). — Rev. Med. Toulouse 1: 229–231.

    Google Scholar 

  4. Bachaud M., Massip P., Boneu B. and Armengaud M. (1983): Anticoagulant circulant au cours d'une fievre Q. — Nouv. Press. Med. 12: 963.

    Google Scholar 

  5. Bergmann J.F., Griveau P., Fichet D., Dechy H. and Dorra M. (1985): Une fievre Q atypique: apparition des signes pulmonaires 40 jours apres le debut de la fievre. — Sem. Hop Paris 61: 2077–2078.

    Google Scholar 

  6. Besancenot J.F., Cannard J.F., Janin-Magnificat L., Auplat P.H. and Cortet P. (1983): Fievre Q et anticoagulant circulant. — Nouv. Presse Med. 12: 2188.

    Google Scholar 

  7. Bresina R. (1976): Phase variation phenomenon in Coxiella burnetii. In Kazar J., Ormsbee R.A., Terasevitch I., Rickettsia and rickettsial disease. —Veds. edit., Bratislava: 221–235.

  8. Caminopetros J. (1948): La Q-fever en Grece: le lait source de l'infection pour l'homme et les animaux. —Ann. Parasitol. Hum. Comp. 23: 107–108.

    Google Scholar 

  9. Cardellach F., Font J., Agusti A.P., Ingelmo M. and Balcells A. (1983): Q-fever hemolytic anemia. — J. Infect. Dis. 148: 769.

    Google Scholar 

  10. Coyle P. V., Thompson J., Adgey A.A. et al. (1985): Changes in circulating immune complexe concentrations and antibody titres during treatment of Q-fever endocarditis. — J. Clin. Pathol. 38: 743–746.

    Google Scholar 

  11. Delsol G., Pellegrin M., Voigt J.J. and Fabre J. (1980): Diagnostic value of granuloma with fibrinoid ring. —Am. J. Clin. Pathol. 73: 289–290.

    Google Scholar 

  12. Derghasarian C., Claurin-Joly M., Lazar A., Mailloux-Cerat L. and Pelletier L. (1983): Fievre Q et hepatite granulomateuse. — Union Med. Can. 112: 1070–1073.

    Google Scholar 

  13. Dupont H.L., Hornick R.B., Levin H.S., Rapoport M.I. and Woodward T.E. (1971): Q-fever hepatitis. Ann. Intern. Med. 74: 198–206.

    Google Scholar 

  14. Dupuis G., Peter O., Peacock M., Burgdorfer W. and Haller E. (1985): Immunoglobin responses in acute Q-fever. — J. Clin. Microbiol. 22: 484–487.

    Google Scholar 

  15. Dupuis G., Peter O., Pedrok D. and Petite J. (1985): Aspects cliniques observes lors d'une epidemie de 415 cas de fievre Q. — Schwetz. Med. Wschr. 115: 814–818.

    Google Scholar 

  16. Elouaer R., Blanc L., Andre C. et al. (1984): Anticorps antimitochondries dormant un aspect d'anti M1 cours de la fievre Q. — Gastro enterol. Clin. Biol. 8: 980.

    Google Scholar 

  17. Faure J., Escande J.C., Grataloup G., Massot C.H. and Faure H. (1977): Hepatite granulomateuse rickettsienne: interet de la biopsie hepatique. — Nouv. Presse Med. 6: 2896.

    Google Scholar 

  18. Hogmann C.E. and Heaton J.W. Jr. (1982): Q-fever hepatitis. Clinical manifestations and pathological findings. — Gastroenterology 83: 474–479.

    Google Scholar 

  19. Homberg J.C. (1985): Le point rapide sur les anticorps antimitochondries. — Presse Medicale 25: 1449–1450.

    Google Scholar 

  20. Homberg J.C. (1985): Anticorps anti tissus en hepatologie. — Gastroenterol Clin. Biol. 9: 622–629.

    Google Scholar 

  21. Homberg J.C. (1987): Les anticorps anti tissus en pathologie hepatique. — Concours Medical: 4050–4055.

  22. Kerr M.A. (1986): Circulating immune complexes associated with decreased complement mediated inhibition of immune precipitation with bacterial endocarditis. — Clin. Exp. Immunol. 63: 359–366.

    Google Scholar 

  23. Kimbrough R.C., Ormsbee R.A., Peacock M. et al. (1979): Q-fever endocarditis in the United States. —Ann. Intern. Med. 91: 400–402.

    Google Scholar 

  24. Pellegrin M., Del Sol G., Auvergnat J.C. et al. (1980): Granulomatous hepatitis in Q-fever. — Hum. Pathol. 11: 51–57.

    Google Scholar 

  25. Peter O., Dupuis G., Burgdorfer W. and Peacock M. (1985): Evaluation of the complement fixation and indirect immunofluorescence tests in the early diagnosis of primary Q-fever. — Eur. J. Clin. Microbiol. 4: 394–396.

    Google Scholar 

  26. Raoult D., Drancourt M., De Micco C. et al. (1986): Les hepatites de la fievre Q. A propos de 14 cas, revue de la litterature. — Sem Hop Paris 62: 997–999.

    Google Scholar 

  27. Raoult D., Etienne J., Massip P. et al. (1987): Q-fever endocarditis in the South of France. — J. Infect. Dis. 155: 570–573.

    Google Scholar 

  28. Raoult D. (1988): La fievre Q: infection a Coxiella burnetii. — Encycl. Med. Chir. (Paris, France) Maladies infectieuses. 8077 n. 10,3 — 10p.

  29. Sawyer L.A., Fishbein D.B. and Mac Dade J.E. (1988): Q fever in patients with hepatitis and pneumonia: result of laboratory based on surveillance in the United States. — J. Infect. Dis. 158: 497–498.

    Google Scholar 

  30. Spellman D.W. (1982): Q-fever: a study of 111 conservative cases. — Med. J. Aust. 26: 547–563.

    Google Scholar 

  31. Turk W.P., Howitt G., Turnberg L.A. et al. (1976): Chronic Q-fever. — Quart J. Med. 178: 193–217.

    Google Scholar 

  32. Voigt J.J., Cassigneul J., Delsol G., Vinel J.P., Pau M and Faure J. (1984): Hepatite granulomateuse. A propos de 112 cas chez l'adulte. — Ann. Pathol. 4:78–80.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Levy, P., Raoult, D. & Razongles, J.J. Q-fever and autoimmunity. Eur J Epidemiol 5, 447–453 (1989). https://doi.org/10.1007/BF00140139

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00140139

Key words

Navigation